Clinical Trial: A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496567) titled 'A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)' on March 23.

Brief Summary: Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD).

Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) can treat NVAMD.

The goal of this trial is to learn if tiespectus works as well as aflibercept to treat NVAMD.

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Macular Degeneration Age-Related Macular Degen...